A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.
Sharanya, Sivanand, Samuel, Peña-Llopis, Hong, Zhao, Blanka, Kucejova, Patrick, Spence, Andrea, Pavia-Jimenez, Toshinari, Yamasaki, David J, McBride, Jessica, Gillen, Nicholas C, Wolff, Lorraine, Morlock, Yair, Lotan, Ganesh V, Raj, Arthur, Sagalowsky, Vitaly, Margulis, Jeffrey a, Cadeddu, Mark T, Ross, David R, Bentley, Wareef, Kabbani, Xian-Jin, Xie, Payal, Kapur, Noelle S, Williams, James, Brugarolas